RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Recently acquired Hepatitis C infections in US blood donors
Genotype and geographic distribution of NAT yield blood donations across the continental US
Bruhn, R., Altan, E., Quiner, C., Delwart, E., Bakkour, S., Steele, W., Notari, E. P., Fayed, R., Winkelman, V., Stone, M., Reik, R. A., Kessler, D. A., Williamson, P. C., Anderson, S., Stramer, S. L., Busch, M. P., Custer, B., & Transfusion-Transmissible Infect M (2018). Recently acquired Hepatitis C infections in US blood donors: Genotype and geographic distribution of NAT yield blood donations across the continental US. Transfusion, 58(Suppl 2), 20A-20A. https://doi.org/10.1111/trf.14903
BBC2-MN3-24 Conclusion: Our findings support the trends of stable 1a, decreasing 1b, and increasing 3a HCV prevalence rates in US blood donors, similar to blood donor data reported by Delwart et al (J Infect Dis. 2012 Mar 15;205(6):875-85) and general population patient data reported by Xie et al (Lab Med. 2016 May;47(2):112-8). Subtype 3a is particularly prevalent in individuals who inject drugs across Europe and the US.
